Furthermore, our dose-dependent results indicate that the loss of pro-resolving effects and the worsening of arthritis scores at higher H3R agonist concentrations suggest that establishing an effective dosage may be challenging when translating these findings to human disease. This evidence concerns the gene HRH3 and Arthritis.